Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » $6.8 Million Grant Funds Alzheimer’s Study
Uncategorized

$6.8 Million Grant Funds Alzheimer’s Study

By medwebMay 1, 2003
Share
Facebook Twitter Email

May 20, 2003

$6.8 Million Grant Funds Alzheimer’s Study

CHICAGO— Northwestern University’s Feinberg School of Medicine has received a $6.8 million grant from the National Institutes of Health to unravel the molecular triggers that cause overactivation of glia brain cells that leads to neurodegeneration in Alzheimer’s disease, stroke, and other diseases.

Glia are important cells of the central nervous system that normally help the body mount a response to injury or developmental change but which are chronically activated in certain neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease, or after traumatic brain injury or stroke.

“Knowledge about glia-neuron interactions will provide insight into signaling pathways to provide new drug discovery targets for Alzheimer’s disease and other critical neurodegenerative events,” said Linda Van Eldik, PhD, professor of cell and molecular biology at the Feinberg School and principal investigator of the program project grant.

Dr. Van Eldik explained that although the overactivation of glia seen in Alzheimer’s disease is believed to play a critical role in the development and progression of neurodegeneration, the molecular mechanisms underlying the process have received little attention.

She and her colleagues believe the four projects in this grant will provide insight into fundamental cell biology changes that might be amenable to modulation by a small molecule compound, such as a drug, and provide a foundation for future research to develop experimental drugs to inhibit disease progression.

Van Eldik will collaborate on one of the projects with D. Martin Watterson, PhD, J.G. Searle Professor of Molecular Biology and Biochemistry, professor of molecular pharmacology and biological chemistry at the Feinberg School and director of the Northwestern University Drug Discovery Training Program. Other medical school researchers include Lester (Skip) Binder, PhD, professor of cell and molecular biology; Mary Jo LaDu, PhD, associate professor of medicine and senior scientist at Evanston Northwestern Healthcare Research Institute; Robert J. Vassar, PhD, associate professor of cell and molecular biology; Robert Berry, PhD, professor of cell and molecular biology; and Alfred W. Rademaker, PhD, professor of preventive medicine.

The Northwestern Drug Discovery Program also recently received two training grants from the NIH. The first was a competitive renewal for five years of a National Institute on Aging-funded predoctoral/postdoctoral training grant, Drug Discovery for Age-related Disorders. The second grant, from the National Institute for General Medical Sciences, will fund five undergraduates from quantitative backgrounds to pursue summer research. The program is called DARE, for Drug Discovery Academic Research Experience.

Share. Facebook Twitter Email

Related Posts

Mar 29, 2023

Adolescent Sexual Health Program Receives Funding for Social Marketing Campaign

Mar 29, 2023

Lurie Cancer Center Receives Merit Extension from NCI

Oct 20, 2021

Drug Combination May Reduce Risk of Leukemia Relapse

Mar 26, 2020

Comments are closed.

Latest News

Biological Aging Increases Risk of Depression, Anxiety in Adults 

Jun 7, 2023

Developing New Nanoparticle Treatments for Brain Tumors

Jun 6, 2023

Newly Discovered Mechanisms Increase Chemotherapy Resistance in Breast Cancer 

Jun 5, 2023

Improving Cancer Detection for Women with Dense Breasts

Jun 5, 2023

Transcription Factor Prevents Bone Frailty in Chronic Kidney Disease

Jun 2, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
ANB05555
ANB08990
ANB09022
ANB09063
ANB09008
ANB08781
ANB08971
ANB09000
ANB08992
ANB09015
ANB09058
ANB09048

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.